Astrazenenca Pharma gets CDSCO nod to import Durvalumab solutions

Astrazeneca Pharma India said that it has received permission from Central Drugs Standard Control Organisation (CDSCO) to import for sale and distribution of Durvalumab solutions (IMFINZI) in India.